Animal Health Industry: Michael Castor’s Next Promising Pick Is Here
Animal health industry: There are hundreds of different “investment gurus” lauded by the financial press as the names retail investors should...
Posts Tagged ‘NASDAQ:NPSP’
NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY), Alexion Pharmaceuticals, Inc. (ALXN): Three Justifications for the High Cost of Gattex
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has priced its Gattex drug for short bowel syndrome, or SBS, at $295,000, expecting to make peak sales of $350...
Cardinal Health, Inc. (CAH), NPS Pharmaceuticals, Inc. (NPSP), Anacor Pharmaceuticals Inc (ANAC): Checking Back In On Michael Castor’s Favorite Healthcare Trio
We discussed Michael Castor’s Sio Capital earlier this summer, and in case you need convincing of why we called him “the next David Einhorn...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than...
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can...
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use...
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and...
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we’ve seen from the smart money, out of the entire stock market...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing...
Apple Inc. (AAPL), Google Inc (GOOG): The Media is Dead Wrong About Hedge Funds
It’s time to set the record straight. Many members of the media have reacted negatively to the development that hedge funds will be allowed to advertise...
Michael Castor’s Sio Capital Knows How to Beat the Market: Cardinal Health Inc (CAH), Small Pharma & More
There are thousands of hedge funds in action today–about 8,000 to be exact–but there are those that stand out amongst the crowd. Michael Castor...
American Realty Capital Properties Inc (ARCP), LIBERTY GLOBAL PLC (LBTYK) – Best Hedge Fund Managers: David Simon’s Stock Picks
We have read dozens of articles about hedge funds and hedge fund advertising over the last few weeks. None of them were 100% accurate and most of them...
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don’t have to imagine...
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
MannKind Corporation (NASDAQ:MNKD) investors should pay attention to a decrease in hedge fund interest recently. According to most stock holders, hedge...
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In...
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
Celldex Therapeutics, Inc. (NASDAQ:CLDX) investors should be aware of an increase in hedge fund interest lately. In the financial world, there are plenty...
NPS Pharmaceuticals, Inc. (NPSP), Pfizer Inc. (PFE): The Profitable Business of Developing Orphan Drugs
“Making every patient count” is a catchy phrase that is perhaps most meaningful for biotech companies like NPS Pharmaceuticals, Inc. (NASDAQ...
Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) investors should pay attention to an increase in hedge fund interest in recent months. To most stock holders...
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds and Insiders Are Bearish, What Should You Do?
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) shareholders have witnessed a decrease in hedge fund interest recently. If you’d ask most shareholders,...
NPS Pharmaceuticals, Inc. (NPSP), Vertex Pharmaceuticals Incorporated (VRTX): Double-Digit Returns from the Biotechnology Strategy
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time. Since inception, the SPDR S&P Biotech ETF has...
Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?
What goes up must come down. Or can it just keep going up? Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron...
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds’ portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge...
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has seen a decrease in enthusiasm from smart money in recent months. According to most investors, hedge funds...
Sio Capital’s Healthcare Stock Picks: Cardinal Health, Inc. (CAH), CareFusion Corporation (CFN), NPS Pharmaceuticals, Inc. (NPSP)
Hedge funds as a group have been underperforming the S&P 500 index for a very long time, and this doesn’t sit well with investors. The reason is...
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home. The biotech announced yesterday that it had reacquired the ex-North America rights...
It’s Time for AstraZeneca plc (ADR) (AZN) to Save Its Future
The hits keep coming at AstraZeneca plc (ADR) (NYSE:AZN). The struggling big pharma player has seen its stock taken down more than 6% so far in 2013,...
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs — medications meant for small patient populations with rare, dangerous diseases — can be a rewarding business for biotech firms...
3 Stocks to Get on Your Watchlist: NPS Pharmaceuticals, Inc. (NPSP) and More
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on...
5 Health Care Stocks Slumping in 2013: NPS Pharmaceuticals, Inc. (NPSP), OraSure Technologies, Inc. (OSUR)
Stocks are rolling along unchallenged, surging to highs not seen since 2007. Investors are partying like it’s before the recession, but with many...
